Home/Recalls/CANADA-48121
Health CanadaGeneral Alert

Pradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with Pr...

Published: December 21, 2012Recall ID: 48121Category: generalCountry: Canada

Product Description & Identification

Pradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with Prosthetic Heart Valves Requiring Anticoagulant Treatment Due to their Valvular Status - For Health Professionals

Additional Source Details

FieldValue
N I D48121
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/pradaxapradax-dabigatran-etexilate-new-contraindication-patients-prosthetic-heart
Title Pradaxa/Pradax (dabigatran etexilate) - New Contraindication in Patients with Prosthetic Heart Valves Requiring Anticoagulant Treatment Due to their Valvular Status - For Health Professionals
Archived1
CategoryDrugs
Last updated2012-12-21
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert